Singer S, Maki RG, O’Sullivan B: Soft tissue sarcoma. In DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 9th edition. Edited by: DeVita VT, Lawrence TS, Rosenberg SA, DePinho RA, Weinberg RA. Philadelphia PA, USA: Lippincott Williams & Wilkins; 2011:Chapter 115. 21. Zetser
A, Levy-Adam F, Kaplan V, Gingis-Velitski S, Bashenko Y, Schubert S, Flugelman MY, Vlodavsky I, Ilan N: Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci 2004, 117:2249–2258.PubMedCrossRef 22. Cohen-Kaplan V, Doweck I, Naroditsky I, Vlodavsky I, Ilan N: Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression. Cancer Res 2008, 68:10077–10085.PubMedCentralPubMedCrossRef 23. Cohen-Kaplan Selleckchem Doramapimod V, Naroditsky I, Zetser A, Ilan N, Vlodavsky I, Doweck I: Heparanase induces VEGF C and facilitates tumor lymphangiogenesis. Int J Cancer 2008, 123:2566–2573.PubMedCentralPubMedCrossRef
24. Masola V, Maran C, Tassone E, Zin A, Rosolen A, Onisto M: Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion. BMC Cancer 2009, 9:304.PubMedCentralPubMedCrossRef 25. Friedmann Y, TH-302 price Vlodavsky I, Aingorn H, Aviv A, Peretz T, Pecker I, Pappo O: Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am J Pathol 2000, 157:1167–1175.PubMedCentralPubMedCrossRef 26. Koliopanos A, Friess H, Kleeff J, Shi X, Liao Q, Pecker I, Vlodavsky I, Zimmermann A, Buchler MW: Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res 2001, 61:4655–4659.PubMed 27. Maxhimer JB, Quiros RM, Stewart R, Dowlatshahi K, Gattuso P, Fan M, Prinz RA, Xu X: Heparanase-1 4��8C expression is associated with the metastatic potential of breast cancer. Surgery 2002, 132:326–333.PubMedCrossRef 28. Wang LL, Yustein
J, Louis C, Russell HV, Pappo AS, Paulino A, Nuchtern JG, Chintagumpala M: Solid Tumors of Childhood. In DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 9th edition. Edited by: DeVita VT, Lawrence TS, Rosenberg SA, DePinho RA, Weinberg RA. Philadelphia PA, USA: Lippincott Williams & Wilkins; 2011:Chapter 123. Competing interests The authors declare that they have no competing interests. Authors’ contributions OK carried out the histological staining and collected the clinical data. NI was responsible for the heparanase laboratory, including the staining, and helped to draft the manuscript. IN and OBI deciphered the stained samples. IV participated in the design of the study and helped to draft the manuscript. GB analyzed the pathological and clinical data, made the statistical analysis, and wrote the manuscript. All authors read and approved the final manuscript.”
“Temsirolimus molecular weight Background Gastric carcinoma (GC) remains one of the most common and lethal malignancies worldwide [1].